Adithya Mathews
Cardiovascular Disease · Brooksville, FLNPI 1750743183
Payments from drug & device makers
Across 380 payments — averaging $98.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$10K
- Medtronic$4K
- Penumbra, Inc.$4K
- Abbott$4K
- Boston Scientific$4K
- Edwards Lifesciences$2K
- plus $10K from 26 others
What the payments were for
- Consulting fees$1500%
- Speaking & faculty fees$3,69810%
- Travel & lodging$16,79245%
- Food & beverage$16,06143%
- Education$6672%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 58 | $9,826 |
| Medtronic(2 entities) | 39 | $4,219 |
| Penumbra, Inc. | 23 | $4,090 |
| Abbott | 44 | $3,874 |
| Boston Scientific | 31 | $3,562 |
| Edwards Lifesciences | 21 | $2,252 |
| Angiodynamics, Inc. | 7 | $1,979 |
| Philips North America LLC | 8 | $1,027 |
| Stryker | 30 | $1,021 |
| Medical Device Business Services, Inc. | 28 | $983 |
| Johnson & Johnson | 20 | $630 |
| AstraZeneca | 6 | $524 |
| Shockwave Medical, Inc | 7 | $486 |
| Astellas Pharma US Inc | 7 | $423 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $353 |
| Cardiovascular Systems Inc. | 6 | $316 |
| Cardiva Medical, Inc. | 4 | $267 |
| Abiomed | 3 | $231 |
| Novartis | 6 | $197 |
| Biosense Webster, Inc. | 2 | $155 |
| Convatec Inc. | 1 | $148 |
| Heartflow, Inc. | 1 | $142 |
| W. L. Gore & Associates, Inc. | 2 | $113 |
| Chiesi USA, Inc. | 3 | $108 |
| Artivion, Inc. | 1 | $98 |
| Cardiofocus, Inc. | 1 | $86 |
| Biotronik Inc. | 2 | $66 |
| Veryan Medical Incorporated | 1 | $60 |
| Terumo Medical Corporation | 2 | $56 |
| Teleflex LLC | 2 | $39 |
| Pfizer | 1 | $19 |
| Venclose Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$9,019
- CT THROMBECTOMY SYSTEM KIT$9,019
- Indigo System$3,688
- COREVALVE EVOLUT R$2,136
- AngioVac$1,820
- XACT$1,580
- GENERAL VASCULAR ACCESS$1,215
- US Und$620
- Carto 3$563
- Edwards SAPIEN 3 Transcatheter Heart Valve$540
- Micra$406
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$406
- XARELTO$396
- FARXIGA$357
- Diamondback Coronary$268
- AVVIGO Guidance System$249
- WATCHMAN Access System$241
- GENERAL - STRUCTURAL HEART$227
- CARDIOMEMS$221
- Varithena Administration Pack$215
How this compares
$37,368 in reported general payments places this provider in the 80th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 19 | $23,908 |
| EliquisApixaban | 20 | $21,665 |
| XareltoRivaroxaban | 15 | $17,755 |
| Ranolazine ErRanolazine | 23 | $2,036 |
| Carvedilol | 130 | $1,586 |
| Nebivolol Hcl | 13 | $1,140 |
| ClopidogrelClopidogrel Bisulfate | 66 | $742 |
| Amiodarone Hcl | 21 | $655 |
| Metoprolol Tartrate | 86 | $642 |
| Metoprolol Succinate | 34 | $589 |
| Atorvastatin Calcium | 46 | $477 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 47 | $468 |
| Nitroglycerin | 28 | $405 |
| Spironolactone | 33 | $347 |
| Furosemide | 61 | $310 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $197 | $23,90819 claims |
| PfizerEliquis | $19 | $21,66520 claims |
| Johnson & JohnsonXarelto | $630 | $17,75515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Brooksville
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.